They found BRCA mutations in 26 of 98 ovarian cancer patients (28%), also reporting the Mexican founder mutation BRCA1 ex9-12del in 35% of their patients from central Mexico [39]. This evidence concerns the gene BRCA1 and ovarian cancer.